About Ozone Pharmaceutical
Ozone Pharmaceutical is a publicly listed company based in Delhi (India) founded in 1991. A diversified range of generic medicines is manufactured. The company has 2,164 employees. Its chief executive, as recorded, is Gaurav Bagri. Its Indian entity Ozone Pharmaceuticals Limited reported revenue of ₹337 Cr. Ozone Pharmaceutical offers products and services including Proton and Research and Development Services. Its focus areas include Traditional Pharmaceuticals.
Company details
Ozone Pharmaceutical was established in 1991 and is headquartered in Delhi, India. Generic medicines across various therapeutic categories are produced by the company within the pharmaceutical sector. Operations focus on manufacturing processes to support diversified product lines. The business serves domestic and potentially international markets from its Indian base. Leadership is provided by CEO Gaurav Bagri, with the official domain ozonpharma.com maintained for digital access.
- Headquarters Delhi, India
- Employees 2,164
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ozonepharma.com
- Social LinkedIn X Facebook Instagram
- Legal Name Ozone Pharmaceuticals Limited
- Date of Incorporation 13 Mar, 1991
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹337 Cr
FY 2025 · -1% YoY
- Net Loss-₹8.79 Cr
FY 2025 · -3% margin
- EBITDA₹17.19 Cr
FY 2025 · 5% margin
- Employee Count2,164
Associated legal entities of Ozone Pharmaceutical
Ozone Pharmaceutical operates through Ozone Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ozone Pharmaceuticals Limited CIN U99999DL1991PLC043461 | Active | 13 Mar 1991 | New Delhi, Delhi | ₹337 Cr | 2,164 | 8 | View details |
Products & Services of Ozone Pharmaceutical
Ozone Pharmaceutical offers a comprehensive portfolio of products and services, including Proton and Research and Development Services.
Proton is offered as a division focusing on health products and medicines
Services are provided that emphasize the development of new medicines and improvement of existing ones
Board of directors of Ozone Pharmaceuticals Limited (Ozone Pharmaceutical)
Ozone Pharmaceuticals Limited is the primary company behind Ozone Pharmaceutical. The board of Ozone Pharmaceuticals Limited currently have 8 directors; the longest-serving is Subhash Chander Sehgal, appointed in 1996. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subhash Chander Sehgal DIN 00540689 | Managing Director | 21 Jun 1996 | 30 yrs 4 mo | Ozone Pharmaceuticals Limited |
| Geeta Sehgal DIN 01362265 | Director | 30 Dec 2009 | 16 yrs 10 mo | Ozone Pharmaceuticals Limited |
| Akarsh Kashyap DIN 00307538 | Director | 19 Oct 2015 | 11 yrs | Ozone Pharmaceuticals Limited |
| Dipak Kumar Singh DIN 02550056 | Director | 01 Feb 2016 | 10 yrs 9 mo | Ozone Pharmaceuticals Limited |
| Anupam Verma DIN 02763043 | Whole-time director | 01 Feb 2021 | 5 yrs 9 mo | Ozone Pharmaceuticals Limited |
| Neelam Oberoi DIN 01384875 | Director | 01 Jun 2021 | 5 yrs 5 mo | Ozone Pharmaceuticals Limited |
| Anju Bala DIN 09744384 | Director | 21 Sep 2022 | 4 yrs 1 mo | Ozone Pharmaceuticals Limited |
| Surender Pal Mahi DIN 11119275 | Additional Director | 26 May 2025 | 1 yr 5 mo | Ozone Pharmaceuticals Limited |
People of Ozone Pharmaceutical
6 people are tracked at Ozone Pharmaceutical (4 in leadership, 2 in team); the tracked headcount is 2,164.
| Name | Role | Group |
|---|---|---|
Gaurav Bagri | CEO | Leadership |
S C Sehgal | Founder- Chairman & Managing Director | Leadership |
Ashok Kumar Sadhusaran Pandey | General Manager Operations | Leadership |
Gaurav Jindal | Head Of Finance And Accounting | Leadership |
Naved Ali Khan | National Operations Manager | Team |
Tanshi Mehan | Assistant Manager | Team |
Complete people profiles for Ozone Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ozone Pharmaceutical
Figures of Ozone Pharmaceuticals Limited, the primary company behind Ozone Pharmaceutical, for FY 2025. Revenue was ₹337 Cr (-1% year on year). Net loss was -₹8.79 Cr (-3% margin). EBITDA was ₹17.19 Cr (5% margin). Revenue has grown at a compounded annual rate of +8% over three years and +12% over five years.
- ₹337 CrRevenue · FY 2025 · -1% YoY
- -₹8.79 CrNet loss · -3% margin
- ₹17.19 CrEBITDA · 5% margin
- ₹5.36 CrPaid-up capital
- 2,164Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ozone Pharmaceuticals Limited are on its company page.
Detailed financial statements for Ozone Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Ozone Pharmaceutical
The website of Ozone Pharmaceutical (ozonepharma.com) receives about 5.7K visits a month.
- Monthly visits5.7K
▲ 29.4% vs previous month
Websites whose visitors overlap most with Ozone Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ozoneayurvedics.com | ozoneayurvedics.com | 100% | #1,463,576 | – | |
| ozonegp.com | 66% | #9,705,314 | View details |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Ozone Pharmaceutical (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ozone Pharmaceutical
Complete news archive for Ozone Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ozone Pharmaceutical
Ozone Pharmaceutical was founded in 1991.
Ozone Pharmaceutical is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Gaurav Bagri is the CEO of Ozone Pharmaceutical, as recorded in our data.
Ozone Pharmaceutical has 2,164 employees.
The primary company behind Ozone Pharmaceutical, Ozone Pharmaceuticals Limited, reported revenue of ₹337 Cr for FY 2025, down 1% year on year.
Ozone Pharmaceutical was established in 1991 and is headquartered in Delhi, India. Generic medicines across various therapeutic categories are produced by the company within the pharmaceutical sector. Operations focus on manufacturing processes to support diversified product lines. The business serves domestic and potentially international markets from its Indian base. Leadership is provided by CEO Gaurav Bagri, with the official domain ozonpharma.com maintained for digital access.
Ozone Pharmaceutical offers Proton and Research and Development Services.
Ozone Pharmaceutical operates through Ozone Pharmaceuticals Limited.
The legal entities of Ozone Pharmaceutical currently have 8 directors, including Geeta Sehgal, Anju Bala, Akarsh Kashyap and others.